TMA Elects Abilene Physician President

Translate to Spanish or other 102 languages!

Austin I. King, MD named Texas Medical Association president
Austin I. King, MD named Texas Medical Association president

Mega Doctor News

- Advertisement -

The Texas Medical Association (TMA) has elected Austin I. King, MD, of Abilene as its 149th president. TMA’s House of Delegates, the association’s policymaking body, elected Dr. King today during TMA’s annual conference in Fort Worth.

“I am honored to lead and advocate on behalf of the more than 47,000 physicians of TMA,” said Dr. King. “I look forward to working with our members to find ways to improve Texas’ health care.”

The Abilene otolaryngologist -an ear, nose, and throat specialist – described priorities for his year as TMA president. “Physicians and patients both are challenged by a dysfunctional health system, which tends to drive us apart,” he said. “It is only by working together that patients and their physicians can improve the system and make it work.”

- Advertisement -

As America’s health care system evolves, Dr. King said he believes TMA must continue to preserve the autonomy of physicians and the integrity of the patient-physician relationship. “We often cannot control change,” he said, “but we can control how we respond. I believe patients and physicians must come together to reclaim health care. Only together can we face the challenge of improving health care for future generations.” MDN

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -